Breaking News

UCB SA (0NZT)

Symbol	Exchange	Currency
UCB	Brussels	EUR	Real-time
UCBb	BATS Europe	EUR	Delayed
UCBJY	OTC Markets	USD	Delayed
0NZT	London	EUR	Real-time
UCB	TradeGate	EUR	Delayed
UCB	Frankfurt	EUR	Delayed
UCB	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

119.60 +0.90 +0.76%

11:35:59 - Closed. Currency in EUR ( Disclaimer )

Type: Equity

Market: United Kingdom

ISIN: BE0003739530

SEDOL: B28MZM8

Volume: 9,485
Bid/Ask: 118.15 / 120.70
Day's Range: 117.55 - 120.20

UCB L Company Profile

Get an in-depth profile of UCB SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

8767

Equity Type

DRC

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company’s primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson’s disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer’s disease; minzasolmin and UCB0222 for Parkinson’s disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Contact Information

Address Allée de la Recherche, 60
Brussels, 1070
Belgium

Phone 32 2 559 99 99

Fax 32 2 559 99 00

Web www.ucb.com

Top Executives

Name	Age	Since	Title
Jan Berger	67	2019	Independent Director
Jean-Christophe Tellier	65	2014	CEO & Executive Director
Susan Gasser	69	2021	Independent Director
Cyril Janssen	53	2015	Director
Charles-Antoine Emmanuel T. Janssen	53	2012	Director
Albrecht De Graeve	69	2010	Director
Ulf Arne Wiinberg	66	2016	Independent Director
Pierre L. Gurdjian	63	2016	Independent Director
Jonkheer Cédric van Rijckevorsel	54	2014	Director
Jonathan M. Peacock	66	2021	Independent Chair of the Board
Alan John Blinken	-	-	Honorary Director
Daniel Janssen	88	-	Honorary Deputy Chairman
Gerhard N. Mayr	78	2005	Honorary Chairman
Georges Jacobs de Hagen	84	2005	Honorary Chairman
Diégo du Monceau de Bergendal	74	1984	Honorary Chairman
Karel Boone	81	2000	Honorary Chairman
Arnoud de Pret Roose de Calesberg	80	2005	Honorary Director
Frederic Roch Doliveux	68	2005	Honorary Director
Thomas Fulton Wilson McKillop	81	2009	Honorary Director
Prince Lorenz	-	2001	Honorary Director
Peter J. Fellner	81	2005	Honorary Director
Norman J. Ornstein	76	2008	Honorary Director
Guy Keutgen	-	1990	Honorary Director
Mark Eyskens	-	2005	Honorary Chairman
Jean-Pierre Kinet	71	2008	Honorary Director
Gaëtan van de Werve	-	2006	Honorary Director
Jean van Rijckevorsel	-	1992	Honorary Director
Jean-Louis Vanherweghem	-	-	Honorary Director
Alice Dautry	74	2015	Honorary Director
Dame Kay Davies	73	2014	Independent Director
Maelys Castella	58	2023	Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

UCB Comments

Write your thoughts about UCB L

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Randall Pharasyn Mar 29, 2023 10:39AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Anti-Psoriasis Drug May Soon Be Approved in the U.S and is a potential blockbuster

2 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="209412000">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="209412000" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="209412000" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="209412000">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	37,857.6	+58.6	+0.16%
US 500	5,057.8	+6.4	+0.13%
Dow Jones	37,798.97	+63.86	+0.17%
S&P 500	5,051.41	-10.41	-0.21%
Nasdaq	15,865.25	-19.77	-0.12%
S&P 500 VIX	18.40	+0.01	+0.05%
Dollar Index	106.180	+0.182	+0.17%

Crude Oil WTI	85.28	0.00	0.00%
Brent Oil	90.08	+0.10	+0.11%
Natural Gas	1.688	+0.014	+0.84%
Gold	2,400.25	+0.65	+0.03%
Silver	28.210	+0.020	+0.07%
Copper	4.2983	+0.0018	+0.04%
US Soybeans	1,145.00	-13.00	-1.12%

U.S. 10Y	4.670	+0.010	+0.21%
U.S. 30Y	4.766	+0.009	+0.18%
U.S. 5Y	4.698	+0.016	+0.34%
U.S. 3M	5.402	+0.015	+0.28%
US 10Y T-Note	107.58	-0.09	-0.09%
Euro Bund	131.37	-0.54	-0.41%
10-2 Yield Spread	-31.72	+6.18	+-16.31%

Apple	169.38	-3.31	-1.92%
Alphabet A	154.40	-0.46	-0.30%
Tesla	157.11	-4.37	-2.71%
Amazon.com	183.32	-0.30	-0.16%
Netflix	617.52	+10.37	+1.71%
Meta Platforms	499.76	-0.47	-0.09%
Bank of America	34.69	-1.26	-3.50%

Recent Quotes

	Name	Price	Chg.	Chg. %
	0NZT	119.60	+0.90	+0.76%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	157.11	-2.71%	96.50M
AAPL	169.38	-1.92%	72.65M
AMD	163.46	+1.96%	55.04M
NVDA	874.15	+1.64%	36.77M
MSFT	414.58	+0.23%	16.70M
SMCI	976.30	+10.60%	6.91M
BRKa	599,280	-0.86%	12.75K

Name	Last	Chg. %	Vol.
SMCI	976.30	+10.60%	6.91M
GL	60.00	+7.51%	4.98M
UNH	469.14	+5.28%	11.67M
VFC	12.58	+3.54%	10.35M
LW	82.07	+2.65%	3.05M
SCHW	73.05	+2.56%	11.74M
MS	89.12	+2.45%	16.95M

Name	Last	Chg. %	Vol.
LYV	92.26	-7.53%	9.64M
ALB	114.11	-5.30%	3.47M
NTRS	79.56	-4.96%	3.08M
PARA	10.43	-4.31%	5.82M
BAC	34.69	-3.50%	90.79M
AMT	172.19	-3.33%	3.66M
HOLX	75.11	-3.13%	1.76M